Expand RCUS Menu
RCUS MENU

RCUS Latest Press Releases

-- December 12, 2025 --

Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio Business Wire 8:30 AM

-- December 9, 2025 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 6:00 PM

-- November 18, 2025 --

Arcus Biosciences to Participate in Two Upcoming Investor Conferences Business Wire 4:05 PM

-- October 30, 2025 --

Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock Business Wire 11:35 PM
Arcus Biosciences Announces Commencement of Public Offering of Common Stock Business Wire 4:01 PM

-- October 28, 2025 --

Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update Business Wire 4:05 PM

-- October 19, 2025 --

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia Business Wire 7:00 PM

-- October 12, 2025 --

Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study Business Wire 6:05 PM

-- October 9, 2025 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- October 6, 2025 --

Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event Business Wire 8:00 AM

-- September 24, 2025 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- September 8, 2025 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM

-- September 2, 2025 --

Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation Business Wire 4:05 PM

-- August 20, 2025 --

Arcus Biosciences to Participate in Three Upcoming Investor Conferences Business Wire 4:05 PM

-- August 6, 2025 --

Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update Business Wire 4:05 PM

-- July 24, 2025 --

Arcus Biosciences Announces New Employment Inducement Grants Business Wire 4:35 PM
Market Data Delayed 15 Minutes